http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2136122-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1395458e1d59a7af5a45a76690954dac |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6803 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate | 1984-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db8704b6cc9412da92f7478d62cf2384 |
publicationDate | 1984-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | GB-2136122-A |
titleOfInvention | A Method of Determining the Oxidizing Activity of a Biological Liquid, and a Mammalian Lens- derived Reagent for use in the Method |
abstract | A reagent based on homogenized mammal lenses which have been dialysed and optionally freeze-dried for preservation is used for exact, reproducible measurement of the oxidizing activity of a biological liquid more particularly serum. A known method is used to test two samples of the biological liquid treated with the reagent, one sample having been incubated at from 10 DEG C to 40 DEG C for 20 to 4 hours and the other sample not having been incubated, the oxidising activity of the liquid being determined from the difference in the two test results. A reduction in oxidizing activity following administration of a drug for treatment of cataract indicates that the drug is effective. |
priorityDate | 1983-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.